Cerus Gets a New Board Chairman

Blood-transfusion safety-systems maker Cerus (NASDAQ: CERS  ) announced today that Daniel Swisher has been elected chairman of the board of directors, effective immediately. 

A director since June 2011, Swisher succeeds B.J. Cassin, who previously gave notice of his intent to retire from the board effective Dec. 31 to devote more time to his family foundation.

Believing the blood safety specialist is well positioned because of its current efforts around the PMA submissions for plasma and platelets in the U.S., Swisher said, "Cerus has been committed to improving blood safety for over two decades, and I am excited to assume the role of Chair of the Board for the next phase of the company's progress in delivering on this commitment."

Swisher, age 50, has served as chief executive officer and board member of biotech Sunesis Pharmaceuticals since 2003, and as Sunesis' president since 2005. He joined Sunesis in 2001, previously serving as chief business officer and CFO. Before joining the biotech, he served in various management roles, including senior vice president of sales and marketing for ALZA from 1992 to 2001, and holds a B.A. from Yale University and an M.B.A. from the Stanford Graduate School of Business.

Cerus President and CEO William "Obi" Greenman thanked Cassin for his 21 years of service and said: "Under his leadership, Cerus has reached many important milestones, including our European launch and commercial growth, as well as the recent regulatory progress in the U.S. While we will miss B.J.'s contributions and steady perseverance, we feel privileged to have Dan lead the Board going forward."

Based in Concord, Calif., Cerus markets and sells its Intercept blood system for both platelets and plasma in Europe, the Commonwealth of Independent States, the Middle East, and selected countries in other regions around the world. In the U.S., Cerus is seeking regulatory approval of the system for plasma and platelets while it is in clinical development for red blood cells.

Read/Post Comments (1) | Recommend This Article (0)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On December 14, 2015, at 7:47 PM, wck1945 wrote:

    This should be a state of the art for blood banks world wide.

    W. Kendrick,md

Add your comment.

Compare Brokers

Fool Disclosure

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 2692712, ~/Articles/ArticleHandler.aspx, 10/1/2016 8:26:12 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 11 hours ago Sponsored by:
DOW 18,308.15 164.70 0.91%
S&P 500 2,168.27 17.14 0.80%
NASD 5,312.00 42.85 0.81%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/30/2016 4:00 PM
CERS $6.21 Up +0.09 +1.47%
Cerus CAPS Rating: *